Immediate Impact
28 standout
Citing Papers
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
2025 Standout
Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology
2025 Standout
Works of Lavinia Tan being referenced
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
2023
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Lavinia Tan | 80 | 97 | 46 | 12 | 184 | |
| Daniele Pignataro | 100 | 111 | 36 | 18 | 216 | |
| Antonino Carmelo Tralongo | 113 | 49 | 44 | 19 | 221 | |
| Jackie Charman | 148 | 108 | 85 | 16 | 274 | |
| W. Edward Fiets | 60 | 88 | 59 | 15 | 198 | |
| Calogero Mazzara | 91 | 96 | 50 | 9 | 236 | |
| C. Farrell | 158 | 47 | 26 | 8 | 273 | |
| Paola Di Nardo | 97 | 105 | 23 | 16 | 189 | |
| Andrea Barina | 169 | 62 | 51 | 13 | 250 | |
| Lionel Uwer | 137 | 55 | 38 | 14 | 184 | |
| Abdel‐Ghani Azzouqa | 141 | 111 | 42 | 11 | 291 |
All Works
Login with ORCID to disown or claim papers
Loading papers...